ModChemBERT: ModernBERT as a Chemical Language Model
ModChemBERT is a ModernBERT-based chemical language model (CLM), trained on SMILES strings for masked language modeling (MLM) and downstream molecular property prediction (classification & regression).
Usage
Install the transformers library starting from v4.56.1:
pip install -U "transformers>=4.56.1,<5.0.0"
Load Model
from transformers import AutoModelForMaskedLM, AutoTokenizer
model_id = "Derify/ModChemBERT"
tokenizer = AutoTokenizer.from_pretrained(model_id)
model = AutoModelForMaskedLM.from_pretrained(
model_id,
trust_remote_code=True,
dtype="float16",
device_map="auto",
)
Fill-Mask Pipeline
from transformers import pipeline
fill = pipeline("fill-mask", model=model, tokenizer=tokenizer)
print(fill("c1ccccc1[MASK]"))
Architecture
- Backbone: ModernBERT
- Hidden size: 768
- Intermediate size: 1152
- Encoder Layers: 22
- Attention heads: 12
- Max sequence length: 256 tokens (MLM primarily trained with 128-token sequences)
- Tokenizer: BPE tokenizer using MolFormer's vocab (2362 tokens)
Pooling (Classifier / Regressor Head)
Kallergis et al. [1] demonstrated that the CLM embedding method prior to the prediction head was the strongest contributor to downstream performance among evaluated hyperparameters.
Behrendt et al. [2] noted that the last few layers contain task-specific information and that pooling methods leveraging information from multiple layers can enhance model performance. Their results further demonstrated that the max_seq_mha pooling method was particularly effective in low-data regimes, which is often the case for molecular property prediction tasks.
Multiple pooling strategies are supported by ModChemBERT to explore their impact on downstream performance:
cls: Last layer [CLS]mean: Mean over last hidden layermax_cls: Max over last k layers of [CLS]cls_mha: MHA with [CLS] as querymax_seq_mha: MHA with max pooled sequence as KV and max pooled [CLS] as querysum_mean: Sum over all layers then mean tokenssum_sum: Sum over all layers then sum tokensmean_mean: Mean over all layers then mean tokensmean_sum: Mean over all layers then sum tokensmax_seq_mean: Max over last k layers then mean tokens
Note: ModChemBERT’s max_seq_mha differs from MaxPoolBERT [2]. MaxPoolBERT uses PyTorch nn.MultiheadAttention, whereas ModChemBERT's ModChemBertPoolingAttention adapts ModernBERT’s ModernBertAttention.
On ChemBERTa-3 benchmarks this variant produced stronger validation metrics and avoided the training instabilities (sporadic zero / NaN losses and gradient norms) seen with nn.MultiheadAttention. Training instability with ModernBERT has been reported in the past (discussion 1 and discussion 2).
Training Pipeline
Rationale for MTR Stage
Following Sultan et al. [3], multi-task regression (physicochemical properties) biases the latent space toward ADME-related representations prior to narrow TAFT specialization. Sultan et al. observed that MLM + DAPT (MTR) outperforms MLM-only, MTR-only, and MTR + DAPT (MTR).
Checkpoint Averaging Motivation
Inspired by ModernBERT [4], JaColBERTv2.5 [5], and Llama 3.1 [6], where results show that model merging can enhance generalization or performance while mitigating overfitting to any single fine-tune or annealing checkpoint.
Datasets
- Pretraining: Derify/augmented_canonical_druglike_QED_Pfizer_15M (canonical_smiles column)
- Domain Adaptive Pretraining (DAPT) & Task Adaptive Fine-tuning (TAFT): ADME (6 tasks) + AstraZeneca (4 tasks) datasets that are split using DA4MT's [3] Bemis-Murcko scaffold splitter (see domain-adaptation-molecular-transformers)
- Benchmarking:
- ChemBERTa-3 [7]
- classification: BACE, BBBP, TOX21, HIV, SIDER, CLINTOX
- regression: ESOL, FREESOLV, LIPO, BACE, CLEARANCE
- Mswahili, et al. [8] proposed additional datasets for benchmarking chemical language models:
- classification: Antimalarial [9], Cocrystal [10], COVID19 [11]
- DAPT/TAFT stage regression datasets:
- ADME [12]: adme_microsom_stab_h, adme_microsom_stab_r, adme_permeability, adme_ppb_h, adme_ppb_r, adme_solubility
- AstraZeneca: astrazeneca_CL, astrazeneca_LogD74, astrazeneca_PPB, astrazeneca_Solubility
- ChemBERTa-3 [7]
Benchmarking
Benchmarks were conducted using the ChemBERTa-3 framework. DeepChem scaffold splits were utilized for all datasets, with the exception of the Antimalarial dataset, which employed a random split. Each task was trained for 100 epochs, with results averaged across 3 random seeds.
The complete hyperparameter configurations for these benchmarks are available here: ChemBERTa3 configs
Evaluation Methodology
- Classification Metric: ROC AUC
- Regression Metric: RMSE
- Aggregation: Mean ± standard deviation of the triplicate results.
- Input Constraints: SMILES truncated / filtered to ≤200 tokens, following ChemBERTa-3's recommendation.
Results
Click to expandChemBERTa-3 Classification Datasets (ROC AUC - Higher is better)
| Model | BACE↑ | BBBP↑ | CLINTOX↑ | HIV↑ | SIDER↑ | TOX21↑ | AVG† |
|---|---|---|---|---|---|---|---|
| Tasks | 1 | 1 | 2 | 1 | 27 | 12 | |
| ChemBERTa-100M-MLM* | 0.781 ± 0.019 | 0.700 ± 0.027 | 0.979 ± 0.022 | 0.740 ± 0.013 | 0.611 ± 0.002 | 0.718 ± 0.011 | 0.7548 |
| c3-MoLFormer-1.1B* | 0.819 ± 0.019 | 0.735 ± 0.019 | 0.839 ± 0.013 | 0.762 ± 0.005 | 0.618 ± 0.005 | 0.723 ± 0.012 | 0.7493 |
| MoLFormer-LHPC* | 0.887 ± 0.004 | 0.908 ± 0.013 | 0.993 ± 0.004 | 0.750 ± 0.003 | 0.622 ± 0.007 | 0.791 ± 0.014 | 0.8252 |
| MLM | 0.8065 ± 0.0103 | 0.7222 ± 0.0150 | 0.9709 ± 0.0227 | 0.7800 ± 0.0133 | 0.6419 ± 0.0113 | 0.7400 ± 0.0044 | 0.7769 |
| MLM + DAPT | 0.8224 ± 0.0156 | 0.7402 ± 0.0095 | 0.9820 ± 0.0138 | 0.7702 ± 0.0020 | 0.6303 ± 0.0039 | 0.7360 ± 0.0036 | 0.7802 |
| MLM + TAFT | 0.7924 ± 0.0155 | 0.7282 ± 0.0058 | 0.9725 ± 0.0213 | 0.7770 ± 0.0047 | 0.6542 ± 0.0128 | 0.7646 ± 0.0039 | 0.7815 |
| MLM + DAPT + TAFT | 0.8213 ± 0.0051 | 0.7356 ± 0.0094 | 0.9664 ± 0.0202 | 0.7750 ± 0.0048 | 0.6415 ± 0.0094 | 0.7263 ± 0.0036 | 0.7777 |
| MLM + DAPT + TAFT OPT | 0.8346 ± 0.0045 | 0.7573 ± 0.0120 | 0.9938 ± 0.0017 | 0.7737 ± 0.0034 | 0.6600 ± 0.0061 | 0.7518 ± 0.0047 | 0.7952 |
ChemBERTa-3 Regression Datasets (RMSE - Lower is better)
| Model | BACE↓ | CLEARANCE↓ | ESOL↓ | FREESOLV↓ | LIPO↓ | AVG‡ |
|---|---|---|---|---|---|---|
| Tasks | 1 | 1 | 1 | 1 | 1 | |
| ChemBERTa-100M-MLM* | 1.011 ± 0.038 | 51.582 ± 3.079 | 0.920 ± 0.011 | 0.536 ± 0.016 | 0.758 ± 0.013 | 0.8063 / 10.9614 |
| c3-MoLFormer-1.1B* | 1.094 ± 0.126 | 52.058 ± 2.767 | 0.829 ± 0.019 | 0.572 ± 0.023 | 0.728 ± 0.016 | 0.8058 / 11.0562 |
| MoLFormer-LHPC* | 1.201 ± 0.100 | 45.74 ± 2.637 | 0.848 ± 0.031 | 0.683 ± 0.040 | 0.895 ± 0.080 | 0.9068 / 9.8734 |
| MLM | 1.0893 ± 0.1319 | 49.0005 ± 1.2787 | 0.8456 ± 0.0406 | 0.5491 ± 0.0134 | 0.7147 ± 0.0062 | 0.7997 / 10.4398 |
| MLM + DAPT | 0.9931 ± 0.0258 | 45.4951 ± 0.7112 | 0.9319 ± 0.0153 | 0.6049 ± 0.0666 | 0.6874 ± 0.0040 | 0.8043 / 9.7425 |
| MLM + TAFT | 1.0304 ± 0.1146 | 47.8418 ± 0.4070 | 0.7669 ± 0.0024 | 0.5293 ± 0.0267 | 0.6708 ± 0.0074 | 0.7493 / 10.1678 |
| MLM + DAPT + TAFT | 0.9713 ± 0.0224 | 42.8010 ± 3.3475 | 0.8169 ± 0.0268 | 0.5445 ± 0.0257 | 0.6820 ± 0.0028 | 0.7537 / 9.1631 |
| MLM + DAPT + TAFT OPT | 0.9665 ± 0.0250 | 44.0137 ± 1.1110 | 0.8158 ± 0.0115 | 0.4979 ± 0.0158 | 0.6505 ± 0.0126 | 0.7327 / 9.3889 |
Mswahili, et al. [8] Proposed Classification Datasets (ROC AUC - Higher is better)
| Model | Antimalarial↑ | Cocrystal↑ | COVID19↑ | AVG† |
|---|---|---|---|---|
| Tasks | 1 | 1 | 1 | |
| MLM | 0.8707 ± 0.0032 | 0.7967 ± 0.0124 | 0.8106 ± 0.0170 | 0.8260 |
| MLM + DAPT | 0.8756 ± 0.0056 | 0.8288 ± 0.0143 | 0.8029 ± 0.0159 | 0.8358 |
| MLM + TAFT | 0.8832 ± 0.0051 | 0.7866 ± 0.0204 | 0.8308 ± 0.0026 | 0.8335 |
| MLM + DAPT + TAFT | 0.8819 ± 0.0052 | 0.8550 ± 0.0106 | 0.8013 ± 0.0118 | 0.8461 |
| MLM + DAPT + TAFT OPT | 0.8966 ± 0.0045 | 0.8654 ± 0.0080 | 0.8132 ± 0.0195 | 0.8584 |
ADME/AstraZeneca Regression Datasets (RMSE - Lower is better)
Hyperparameter optimization for the TAFT stage appears to induce overfitting, as the MLM + DAPT + TAFT OPT model shows slightly degraded performance on the ADME/AstraZeneca datasets compared to the MLM + DAPT + TAFT model.
The MLM + DAPT + TAFT model, a merge of unoptimized TAFT checkpoints trained with max_seq_mean pooling, achieved the best overall performance across the ADME/AstraZeneca datasets.
| ADME | AstraZeneca | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Model | microsom_stab_h↓ | microsom_stab_r↓ | permeability↓ | ppb_h↓ | ppb_r↓ | solubility↓ | CL↓ | LogD74↓ | PPB↓ | Solubility↓ | AVG† |
| Tasks | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| MLM | 0.4489 ± 0.0114 | 0.4685 ± 0.0225 | 0.5423 ± 0.0076 | 0.8041 ± 0.0378 | 0.7849 ± 0.0394 | 0.5191 ± 0.0147 | 0.4812 ± 0.0073 | 0.8204 ± 0.0070 | 0.1365 ± 0.0066 | 0.9614 ± 0.0189 | 0.5967 |
| MLM + DAPT | 0.4199 ± 0.0064 | 0.4568 ± 0.0091 | 0.5042 ± 0.0135 | 0.8376 ± 0.0629 | 0.8446 ± 0.0756 | 0.4800 ± 0.0118 | 0.5351 ± 0.0036 | 0.8191 ± 0.0066 | 0.1237 ± 0.0022 | 0.9280 ± 0.0088 | 0.5949 |
| MLM + TAFT | 0.4375 ± 0.0027 | 0.4542 ± 0.0024 | 0.5202 ± 0.0141 | 0.7618 ± 0.0138 | 0.7027 ± 0.0023 | 0.5023 ± 0.0107 | 0.5104 ± 0.0110 | 0.7599 ± 0.0050 | 0.1233 ± 0.0088 | 0.8730 ± 0.0112 | 0.5645 |
| MLM + DAPT + TAFT | 0.4206 ± 0.0071 | 0.4400 ± 0.0039 | 0.4899 ± 0.0068 | 0.8927 ± 0.0163 | 0.6942 ± 0.0397 | 0.4641 ± 0.0082 | 0.5022 ± 0.0136 | 0.7467 ± 0.0041 | 0.1195 ± 0.0026 | 0.8564 ± 0.0265 | 0.5626 |
| MLM + DAPT + TAFT OPT | 0.4248 ± 0.0041 | 0.4403 ± 0.0046 | 0.5025 ± 0.0029 | 0.8901 ± 0.0123 | 0.7268 ± 0.0090 | 0.4627 ± 0.0083 | 0.4932 ± 0.0079 | 0.7596 ± 0.0044 | 0.1150 ± 0.0002 | 0.8735 ± 0.0053 | 0.5689 |
Bold indicates the best result in the column; italic indicates the best result among ModChemBERT checkpoints.
* Published results from the ChemBERTa-3 [7] paper for optimized chemical language models using DeepChem scaffold splits.
† AVG column shows the mean score across classification tasks.
‡ AVG column shows the mean scores across regression tasks without and with the clearance score.
Optimized ModChemBERT Hyperparameters
Click to expandTAFT Datasets
Optimal parameters (per dataset) for the MLM + DAPT + TAFT OPT merged model:
| Dataset | Learning Rate | Batch Size | Warmup Ratio | Classifier Pooling | Last k Layers |
|---|---|---|---|---|---|
| adme_microsom_stab_h | 3e-5 | 8 | 0.0 | max_seq_mean | 5 |
| adme_microsom_stab_r | 3e-5 | 16 | 0.2 | max_cls | 3 |
| adme_permeability | 3e-5 | 8 | 0.0 | max_cls | 3 |
| adme_ppb_h | 1e-5 | 32 | 0.1 | max_seq_mean | 5 |
| adme_ppb_r | 1e-5 | 32 | 0.0 | sum_mean | N/A |
| adme_solubility | 3e-5 | 32 | 0.0 | sum_mean | N/A |
| astrazeneca_CL | 3e-5 | 8 | 0.1 | max_seq_mha | 3 |
| astrazeneca_LogD74 | 1e-5 | 8 | 0.0 | max_seq_mean | 5 |
| astrazeneca_PPB | 1e-5 | 32 | 0.0 | max_cls | 3 |
| astrazeneca_Solubility | 1e-5 | 32 | 0.0 | max_seq_mean | 5 |
Benchmarking Datasets
Optimal parameters (per dataset) for the MLM + DAPT + TAFT OPT merged model:
| Dataset | Batch Size | Classifier Pooling | Last k Layers | Pooling Attention Dropout | Classifier Dropout | Embedding Dropout |
|---|---|---|---|---|---|---|
| bace_classification | 32 | max_seq_mha | 3 | 0.0 | 0.0 | 0.0 |
| bbbp | 64 | max_cls | 3 | 0.1 | 0.0 | 0.0 |
| clintox | 32 | max_seq_mha | 5 | 0.1 | 0.0 | 0.0 |
| hiv | 32 | max_seq_mha | 3 | 0.0 | 0.0 | 0.0 |
| sider | 32 | mean | N/A | 0.1 | 0.0 | 0.1 |
| tox21 | 32 | max_seq_mha | 5 | 0.1 | 0.0 | 0.0 |
| base_regression | 32 | max_seq_mha | 5 | 0.1 | 0.0 | 0.0 |
| clearance | 32 | max_seq_mha | 5 | 0.1 | 0.0 | 0.0 |
| esol | 64 | sum_mean | N/A | 0.1 | 0.0 | 0.1 |
| freesolv | 32 | max_seq_mha | 5 | 0.1 | 0.0 | 0.0 |
| lipo | 32 | max_seq_mha | 3 | 0.1 | 0.1 | 0.1 |
| antimalarial | 16 | max_seq_mha | 3 | 0.1 | 0.1 | 0.1 |
| cocrystal | 16 | max_cls | 3 | 0.1 | 0.0 | 0.1 |
| covid19 | 16 | sum_mean | N/A | 0.1 | 0.0 | 0.1 |
Intended Use
- Primary: Research and development for molecular property prediction, experimentation with pooling strategies, and as a foundational model for downstream applications.
- Appropriate for: Binary / multi-class classification (e.g., toxicity, activity) and single-task or multi-task regression (e.g., solubility, clearance) after fine-tuning.
- Not intended for generating novel molecules.
Limitations
- Out-of-domain performance may degrade for: very long (>128 token) SMILES, inorganic / organometallic compounds, polymers, or charged / enumerated tautomers are not well represented in training.
- No guarantee of synthesizability, safety, or biological efficacy.
Ethical Considerations & Responsible Use
- Potential biases arise from training corpora skewed to drug-like space.
- Do not deploy in clinical or regulatory settings without rigorous, domain-specific validation.
Hardware
Training and experiments were performed on 2 NVIDIA RTX 3090 GPUs.
Citation
If you use ModChemBERT in your research, please cite the checkpoint and the following:
@software{cortes-2025-modchembert,
author = {Emmanuel Cortes},
title = {ModChemBERT: ModernBERT as a Chemical Language Model},
year = {2025},
publisher = {GitHub},
howpublished = {GitHub repository},
url = {https://github.com/emapco/ModChemBERT}
}
References
- Kallergis, G., Asgari, E., Empting, M. et al. Domain adaptable language modeling of chemical compounds identifies potent pathoblockers for Pseudomonas aeruginosa. Commun Chem 8, 114 (2025). https://doi.org/10.1038/s42004-025-01484-4
- Behrendt, Maike, Stefan Sylvius Wagner, and Stefan Harmeling. "MaxPoolBERT: Enhancing BERT Classification via Layer-and Token-Wise Aggregation." arXiv preprint arXiv:2505.15696 (2025).
- Sultan, Afnan, et al. "Transformers for molecular property prediction: Domain adaptation efficiently improves performance." arXiv preprint arXiv:2503.03360 (2025).
- Warner, Benjamin, et al. "Smarter, better, faster, longer: A modern bidirectional encoder for fast, memory efficient, and long context finetuning and inference." arXiv preprint arXiv:2412.13663 (2024).
- Clavié, Benjamin. "JaColBERTv2.5: Optimising Multi-Vector Retrievers to Create State-of-the-Art Japanese Retrievers with Constrained Resources." arXiv preprint arXiv:2407.20750 (2024).
- Grattafiori, Aaron, et al. "The llama 3 herd of models." arXiv preprint arXiv:2407.21783 (2024).
- Singh R, Barsainyan AA, Irfan R, Amorin CJ, He S, Davis T, et al. ChemBERTa-3: An Open Source Training Framework for Chemical Foundation Models. ChemRxiv. 2025; doi:10.26434/chemrxiv-2025-4glrl-v2 This content is a preprint and has not been peer-reviewed.
- Mswahili, M.E., Hwang, J., Rajapakse, J.C. et al. Positional embeddings and zero-shot learning using BERT for molecular-property prediction. J Cheminform 17, 17 (2025). https://doi.org/10.1186/s13321-025-00959-9
- Mswahili, M.E.; Ndomba, G.E.; Jo, K.; Jeong, Y.-S. Graph Neural Network and BERT Model for Antimalarial Drug Predictions Using Plasmodium Potential Targets. Applied Sciences, 2024, 14(4), 1472. https://doi.org/10.3390/app14041472
- Mswahili, M.E.; Lee, M.-J.; Martin, G.L.; Kim, J.; Kim, P.; Choi, G.J.; Jeong, Y.-S. Cocrystal Prediction Using Machine Learning Models and Descriptors. Applied Sciences, 2021, 11, 1323. https://doi.org/10.3390/app11031323
- Harigua-Souiai, E.; Heinhane, M.M.; Abdelkrim, Y.Z.; Souiai, O.; Abdeljaoued-Tej, I.; Guizani, I. Deep Learning Algorithms Achieved Satisfactory Predictions When Trained on a Novel Collection of Anticoronavirus Molecules. Frontiers in Genetics, 2021, 12:744170. https://doi.org/10.3389/fgene.2021.744170
- Cheng Fang, Ye Wang, Richard Grater, Sudarshan Kapadnis, Cheryl Black, Patrick Trapa, and Simone Sciabola. "Prospective Validation of Machine Learning Algorithms for Absorption, Distribution, Metabolism, and Excretion Prediction: An Industrial Perspective" Journal of Chemical Information and Modeling 2023 63 (11), 3263-3274 https://doi.org/10.1021/acs.jcim.3c00160
Model discussions
Share what you know. Help others. Build trust.
Loading comments...
Keep it about the model. No spam, scams or personal attacks. Links are not allowed in comments or replies. Comment policy